Jan 05, 2021
Qualigen Therapeutics to Present at the H.C. Wainwright BioConnect 2021 Conference
Dec 18, 2020
Qualigen Therapeutics, Inc. Announces Closing of $12 Million Registered Direct Offering
Dec 16, 2020
Qualigen Therapeutics, Inc. Announces $12 Million Registered Direct Offering
Dec 15, 2020
Qualigen Therapeutics Announces Issuance of U.S. Patent for Expanded Applications of ALAN Anticancer Platform Technology
Dec 08, 2020
Qualigen Therapeutics Announces Board Member Amy Broidrick as EVP, Chief Strategy Officer and Names Sidney Emery, Jr. to its Board
Nov 13, 2020
Qualigen Therapeutics Issues CEO Letter to Stockholders, Reports on Significant Progress and Fiscal Second Quarter Financial Results
Nov 05, 2020
Qualigen Therapeutics Engages STA Pharmaceutical as GMP Manufacturer of AS1411 for Clinical Trials
Oct 28, 2020
Qualigen Therapeutics Receives Positive Pre-IND Response from FDA for the Clinical Development of AS1411 as a Treatment for COVID-19
Oct 08, 2020
Qualigen Therapeutics Enters into Commercialization Agreement for its FastPack® Diagnostic Products in China
Aug 31, 2020
Qualigen Therapeutics Engages IRISYS LLC as GMP Manufacturer for AS1411 Drug Product
Aug 28, 2020
Qualigen Therapeutics Appoints Amy Broidrick to its Board of Directors
Aug 14, 2020
Qualigen Therapeutics Announces Business Highlights and First Quarter Fiscal Year 2021 Financial Results; Has $16 Million in Cash on Hand as of Today
Aug 04, 2020
Qualigen Therapeutics, Inc. Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Jul 30, 2020
Qualigen Therapeutics Begins Shipping FastPack® COVID-19 Antibody Test
Jul 13, 2020
Qualigen Therapeutics CEO Issues Letter to Stockholders
Jul 10, 2020
Qualigen Therapeutics, Inc. Announces Closing of $8 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Jul 08, 2020
Qualigen Therapeutics, Inc. Announces $8 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Jul 07, 2020
Qualigen Therapeutics Engages NFL Hall of Famer Mike Haynes as Advisor to the Company and Spokesman for the FastPack® Rapid Diagnostic System "Which Saved My Life"
Jul 01, 2020
Qualigen Therapeutics Submits Notification to FDA to Commence Distribution of its FastPack® COVID-19 Antibody Test
Jun 04, 2020
Qualigen Therapeutics Receives U.S. Patent Notice of Allowance for its STARS(TM) Technology